On February 27, 2012 Abbott Laboratories, Inc. “(Abbott”) announced it was recalling powder infant formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Michigan, one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas. Products made at this facility can be found across the U.S. and were likely exported to other countries as well. Canadian health officials have also issued a recall warning.
Abbott is recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility. The Company said its investigation is ongoing.
The FDA Announces the Infant Formula Recall Investigation
The same day, the U.S. Food and Drug Administration (“FDA”) announced it is investigating consumer complaints of Cronobacter sakazakii and Salmonella Newport infections. The FDA stated that in all of the cases are reported, each consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, Michigan facility. The FDA further stated it was is alerting consumers to avoid purchasing or using certain powdered infant formula products produced at this facility.
The FDA is addvides consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:
The FDA stated it was investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA stated it has initiated an onsite inspection at the facility and its findings to date include several positive Cronobacter sakazakii results from environmental samples taken and adverse inspectional observations by the FDA investigators. A review of the firm’s internal records also indicate environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.
“As this is a product used as the sole source of nutrition for many of our nation’s newborns and infants, the FDA is deeply concerned about these reports of bacterial infections,” said Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response. “We want to reassure the public that we’re working diligently with our partners to investigate complaints related to these products, which we recognize include infant formula produced at this facility, while we work to resolve this safety concern as quickly as possible.”
How do I know if I bought Abbott Recalled Infant Formula?
In addition to the above, on February 28, 2012 Abbott additionally stated it was recalling one lot of Similac PM 60/40 (Lot # 27032K80 (can) / Lot # 27032K800 (case)) manufactured in Sturgis, Michigan.
To find out if your infant formula is subject to the infant formula recall, look on the bottom of the container for a product code that includes eight numbers or letters.
Then go to this website – https://www.similac.com/contact.html– where you can type in the code to see if your baby formula is on the infant formula recall list.
Call an Infant Formula Recall Lawyer Today About an Infant Formula Recall Lawsuit
If your baby was hospitalized after using Abbott Recalled Infant Formula purchased after August 2021, contact Infant Formula Recall Lawyer Timothy L. Miles about an Infant Formula Recall Lawsuit today and see what an Infant Formula Recall Lawyer can do for you.
Timothy L. Miles, Esq.
Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, and more.
Timothy L. Miles
Hours of Operation